The booming business of longevity and anti-ageing treatments in high society
The longevity business is booming, with high society spending thousands on cutting-edge treatments to extend their lifespan. Silicon Valley billionaires are investing millions into research, aiming to 'reverse all human ailments' and make death a solvable problem. Clinics like Hum2n in London and Clinique La Prairie in Montreux offer advanced anti-ageing procedures. Despite the promises, there is little scientific proof that these treatments work, and some may even pose risks.
Key Points
- Silicon Valley billionaires like Sam Altman and Peter Thiel are investing millions in longevity research
- Clinics like Hum2n and Clinique La Prairie offer advanced anti-ageing procedures
- There is a growing market for longevity products and services, despite limited proof of their effectiveness
Pros
- Cutting-edge treatments offer potential for extended health span and vitality
- Investments from billionaires may lead to breakthroughs in anti-ageing research
Cons
- Lack of concrete scientific evidence on the effectiveness of longevity treatments
- Potential risks and side effects associated with unregulated stem-cell therapies and other treatments